HHS’s big picture for health AI
|
This week Chrissy and I were both at HLTH, talking shop and gathering everyone’s thoughts on what’s going on in health tech. My main takeaway? There’s a lot of excitement about AI’s potential and a lot of questions about what shape regulation will take in 2027.
The Department of Health and Human Services is currently firing the mold for AI safety and practice. It has a clear vision: super intelligent technology should be able to assist and augment the way health care is delivered in the U.S. such that it lowers chronic disease in the country and contracts seemingly ever expanding costs.
Last week, the Center for Medicare and Medicaid Services issued its roadmap for health care “Super Intelligence,” which I wrote about here. In it, the agency describes how HHS has so far prepped the canvas, by bringing together market participants via its health tech ecosystem, turning on a way of paying for SI-enabled care through its experimental ACCESS program, and creating a mechanism for oversight via the Food and Drug Administration’s TEMPO program.
Next, it wants to create a data foundation on which health apps can deliver actionable health advice so patients can manage their own health. A piece of that plan came together this week when the Office of Civil Rights dropped the final HIPAA privacy rule. The new rule makes it easier for patients to use health apps as an emissary, to gather their records for them, while limiting the circumstances under which providers and insurers can push back on those requests.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, December 3, 3–4 p.m. ET / noon–1 p.m. PT.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
